Video: Utah leaders talk prescription drug policy
Prescription drug importation, bulk purchasing programs, upper pricing limits — all of these and more were discussion topics at a panel on prescription drug policy innovation at our recent Utah conference.
Get the latest state-specific policy intelligence for the health care sector delivered to your inbox.
Katelin Lucariello, state advocacy director for the Pharmaceutical Research and Manufacturers of America (PhRMA), Steve Schultz, director of state legislative affairs for the Arthritis Foundation, and Danny Harris, advocacy director for the American Association of Retired Persons (AARP) were panelists on the “Rx Drugs: Market Innovations and Policy Initiatives” panel.
Watch as these leaders engage in an in-depth discussion on some of today’s most prominent prescription drug policies.